HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation
Author:
Affiliation:
1. Department of Rehabilitation, School of Nursing, Jilin University, Changchun, Jilin 130021, P.R. China
2. School of Medicine, Tongji University, Shanghai 200092, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology,General Medicine
Reference32 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges;Glina;J Sex Med,2010
3. Tumor-associated macrophage promotes the survival of cancer cells upon docetaxel chemotherapy via the CSF1/CSF1R-CXCL12/CXCR4 axis in castration-resistant prostate cancer;Guan;Genes (Basel),2021
4. Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and drug administration drug approval summary;Kluetz;Clin Cancer Res,2013
5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments;Journal of Cellular and Molecular Medicine;2024-08
2. Exploring the Potential of CPA4 Knockdown as a Prognostic Biomarker in Inhibiting Endometrial Cancer Proliferation;2024-04-19
3. The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer;International Journal of Molecular Sciences;2024-03-07
4. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation;Cancer and Metastasis Reviews;2024-02-19
5. SWI/SNF chromatin remodelers in prostate cancer progression;Frontiers in Epigenetics and Epigenomics;2024-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3